Editorial Board ::: Current Neuropharmacology

ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)


Volume 15, 8 Issues, 2017


Download PDF Flyer




Current Neuropharmacology

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 72nd of 256 in Neuroscience
  • 24th of 253 in Pharmacology & Pharmacy

Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
T.E. Salt
University College London
Institute of Ophthalmology
London EC1V 9EL
UK


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.365
5 - Year: 3.623

Editorial Board

Editor-in-Chief:

T.E. Salt (Biography
T.E. Salt

Professor Tom Salt obtained his Degrees from The Universities of Cambridge and Bristol, is co-founder and Director of Neurexpert Ltd, and Emeritus Professor at University College London. He has worked in the pharmaceutical industry, and acted as a consultant and adviser to industry.

Professor Salt's research encompasses the pharmacology of neurotransmitters in relation to the sensory system systems, and more recently the functional consequences of neurodegeneration. He has published over 200 research and review papers, and is a member of several editorial boards and Editor in Chief of "Current Neuropharmacology"

)

University College London
Institute of Ophthalmology
London EC1V 9EL
UK



Regional Editor:

N. Iwata (Biography
N. Iwata

Dr. Nobuhisa Iwata obtained a Ph.D. in Pharmacology from Tokyo University of Pharmacy and Life Sciences (Tokyo, Japan), then worked at National Institute of Health Sciences (Tokyo, Japan), Tokyo Medical University (Tokyo, Japan), National Heart, Lung, and Blood Institute (Bethesda, US), and RIEKN Brain Science Institute (Wako, Japan). Currently Dr. Iwata is a full professor in Graduate School of Biomedical Sciences, Nagasaki University. He has published more than 100 scientific publications, including Science, Nature Medicine, Nature Neuroscience, Neuron, Cell Stem Cell, etc.

Dr. Iwata was appointed the Regional Editor of this journal (Current Neuropharmacology, CN), published by Bentham Science Publishers, in 2004.

)

Nagasaki University
Japan


Editorial Board Members:

I. Abraham (Biography
I. Abraham

Dr István Ábrahám obtained his MD in Medical University of Pécs in Hungary and received his PhD degree in Neuroscience at Semmelweis Medical University in Hungary and he received his DSc from Hungarian Academy of Sciences. He currently holds a position of full professor in Institute of Physiology, Szenágothai Research Centre and director of Center for Neuroscience in University of Pécs in Hungary. Dr Ábrahám published 51 original research papers and his citation is over 2000.

)

Univ of Pecs
Pecs
Hungary

G. Akk
Washington University School of Medicine
St. Louis, MO
USA

B. K. Alldredge (Biography
B. K. Alldredge

Dr. Alldredge is a Professor of Clinical Pharmacy and Neurology at the University of California, San Francisco and he serves as Vice Provost-Academic Affairs . His clinical practice and research interests focus on epilepsy, seizure emergencies, prehospital care, and pharmacogenomics. He participates on invited review groups for the National Institutes of Neurological Disorders & Stroke, and he serves as a reviewer for journals in pharmacy, neurology and medicine. His research has been funded by the National Institutes of Health and professional organizations.

)

University of California
San Francisco, CA
USA

J. C. Arnold
The University of Sydney, New South Wales
Australia

M. Avoli (Biography
M. Avoli

Massimo Avoli is a Physician Scientist who performs research as a Faculty member of the Montreal Neurological Institute of McGill University. He is a Professor in the McGill University's Departments of Neurology & Neurosurgery and of Physiology as well as Professor of Human Physiology in the Department of Experimental Medicine at the Sapienza University of Rome. Dr. Avoli’s main interests are directed to the fundamental abnormalities that lead to the generation of seizures by employing electrophysiological recording in in vivo and in vitro experimental models of epilepsy. In his current research, Dr. Avoli explores the role played by inhibitory and excitatory mechanisms in the synchronicity of neuronal networks of the limbic system, and thus in seizure initiation. He is also addressing the changes in excitability that contributes to epileptogenesis in temporal lobe epilepsy as well as the mechanisms of action of anti-epileptic drugs.

)

McGill Univ
Montreal
Canada

K. Ballanyi (Biography
K. Ballanyi

Dr. Ballanyi obtained a Dr. rer. nat. (equivalent to a Ph.D.) in Zoology from the University of Munich in Germany. Currently, he is Professor at the Department of Physiology at the University of Alberta in Edmonton, Canada. Dr. Ballanyi’s main research topic is modulation of rhythmically active neuron-glia networks in newborn mammals by clinically important agents like opioids or methylxanthines and pathological processes like hypoxia and ischemia. He published >130 articles so far. He is also editor of the European Journal of Physiology (Pflügers Archiv) and Frontiers in Physiology (Respiratory Physiology).

)

University of Alberta
Edmonton
Canada

M. L. Barbaccia (Biography
M. L. Barbaccia

Dr. Maria Luisa Barbaccia obtained a MD degree from the University of Milan, Medical School, Italy. Her research activity, mostly focused on various aspects of neuro-psychopharmacology, was performed at the Institute of Pharmacology of Milan University, Milan-Italy (1979-80), Washington D.C.-USA (1980-1988, first at NIMH/St. Elizabeth’s Hospital and later at Georgetown University/FGIN) and Rome-Italy. Currently Dr. Barbaccia is full professor of Pharmacology at the University of Rome Tor Vergata Medical School. She has authored/co-authored more than 90 scientific publications, mostly on peer-reviewed international journals.

)

University of Rome Tor Vergata- Medical School
Rome
Italy

M. Baudry (Biography
M. Baudry

Dean, Graduate College of Biomedical Sciences at Western University of Health Sciences; former professor of biological sciences, neurology and biomedical engineering at University of Southern California; internationally known neuroscientist who has published more than 400 manuscripts in peer-reviewed journals; one of the 100 most-cited neuroscientists in the world, according to the ISI database; served on numerous National Science Foundation and National Institutes of Health studies; graduated from Ecole Polytechnique, Paris in 1971; earned PhD in biochemistry at University of Paris VII in 1977 under the direction of professors J.C. Schwartz and J.P. Changeux, two of France’s most distinguished neurobiologists.

)

University of Southern California
Los Angeles, CA
USA

S. M. Belcher
University of Cincinnati
Cincinnati
USA

S. C. Benoit
University of Cincinnati
Cincinnati, OH
USA

C. Beyer (Biography
C. Beyer

Cordian Beyer obtained his Ph.D. degree in Biology from the University Ulm, Germany, in 1991. Thereafter, he spent several years at the MRC Babraham in Cambridge, UK, and, after returning to Ulm, became in 1996 assistant professor and in 2001 associated professor in the department of Anatomy and Cell Biology. From 2003-2005, he was the Academic Director of the Institute of Anatomy at the University Tuebingen, Germany. Since 2005, he is Head of the Institute of Neuroanatomy at the RWTH Aachen, Germany. Dr. Beyer published more than 200 scientific publications and is in the Editorial Board of several international journals.

)

Universittsklinikum RWTH Aachen
Aachen
Germany

S. Boehm (Biography
S. Boehm

Dr. Boehm obtained an MD from the University of Vienna, Austria, in 1987 and received his postdoctoral education in Vienna and Frankfurt/Main, Germany. He had been Professor of Neuropharmacology at the Medical University of Graz and was appointed Professor of Neuropharmacology at the Medical University of Vienna in 2007. There, he is head of the Department of Neurophysiology and Neuropharmacology at the Center for Physiology and Pharmacology and Director of the Doctoral School. His research focuses on mechanisms underlying pre‐ as well as postsynaptic modulation of synaptic transmission and on mechanisms of action of analgesic as well as anticonvulsant drugs.

)

Medical University of Vienna
Vienna
Austria

U. Bonuccelli
Dipartimento di Neuroscienze-Universita di Pisa
Rome
Italy

Derek Bowie (Biography
Derek Bowie

Dr. Derek Bowie earned his doctorate from the University of London, held postdoctoral fellow positions at the Université Louis Pasteur (France), University of Zurich (Switzerland) and the National Institutes of Health (USA) before joining the faculty at Emory University in Atlanta. He joined McGill in 2002 and is currently a Full Professor and Director of GEPROM, a FRQS-funded research group of McGill, Concordia and Université de Montréal. He serves/served on the editorial boards of several periodicals (e.g. Journal of Physiology, Current Neuropharmacology, European Journal of Neuroscience).

)

McGill Univ.
Montreal
Canada

A. W. Bruijnzeel
University of Florida
Gainesville, FL
USA

I. Bókkon
Semmelweis University.
Budapest
Hungary

G. A. Caldwell (Biography
G. A. Caldwell

Guy A. Caldwell, Ph.D., is a University Distinguished Research Professor at The University of Alabama. He also holds an appointments at the University of Alabama School of Medicine in Birmingham as an Adjunct Research Professor in the Departments of Neurology and Neurobiology, where he is also a scientist in the Center for Neurodegeneration and Experimental Therapeutics. Dr. Caldwell received his undergraduate degree in Biology from Washington & Lee University and his Ph.D. in Cell, Molecular & Developmental Biology from The University of Tennessee. As a postdoc at Columbia University in the lab of 2008 Nobel Laureate, Dr. Martin Chalfie, he was twice named the recipient of fellowships from the National Institutes of Health. Dr. Caldwell serves on the editorial boards of Human Molecular Genetics, Disease Models and Mechanisms, ACS Chemical Neuroscience, and Current Neuropharmacology. Dr. Caldwell was honored in U.S. Congress with the 2005 Carnegie Foundation and Council for the Advancement and Support of Education (CASE) U.S. Professor of the Year award.

)

The University of Alabama
Tuscaloosa
USA

M. J. Christie
The University of Sydney
Sydney
Australia

R.G. Hill (Biography
R.G. Hill

Dr Hill received his academic training at the University of London. He was a lecturer in Pharmacology at the University of Bristol School of Medicine from 1974 to 1983 and supervisor in Pharmacology at Downing College, University of Cambridge from 1983 to 1988. He joined the pharmaceutical industry in 1983 as Head of Biology at the Park Davis Research Unit, Cambridge. In 1988 he joined Smith, Kline and French (UK) as Group Director, Pharmacology. From 1990 until his retirement in 2008 he worked in drug discovery research for Merck / MSD. He serves on the editorial boards of a number of journals, has been a Council Member of the British Pain Society, is President Emeritus, British Pharmacological Society and was coopted Member of Council, Academy of Medical Sciences. Between 1996 and 2003 he was a member of the ABPI R&D committee and was a member of the EFPIA Research Directors Group until 2008. He was a member of the Nuffield Council on Bioethics until 2013 and is a member of the Advisory Council on the Misuse of Drugs.

Dr Hill has published more than 200 peer reviewed papers on the pharmacology of opioids and other analgesic drugs and on the role of substance P, CGRP, bradykinin and other peptides in emesis, nociception and the control of food intake. He is co-author (with J.A. Alexander) of a text book on Postoperative Pain Control and (with HP Rang) of one on Drug Discovery and Development.

)

Imperial College London
London
UK

H. Mancebo
Multispan Inc.,
Hayward, CA
USA

P. J. Nathan (Biography
P. J. Nathan

Prof. Pradeep Nathan is Vice President, CNS Clinical Development and Experimental Medicine at Heptares Therapeutics, and Professor of Neuroscience at Monash University. He read pharmacology and neuroscience at the University of Melbourne followed by a PhD in Neuroscience. He has more than 20 years clinical research experience and held positions in both academia and industry.

Prof. Nathan has published more than 200 research papers and his research has been cited over 8500 times in academic journals. He has received many research awards including the Australian Young Tall Poppy Science Award, the Brain and Behaviour Foundation, Independent Investigator Award and the British Association for Psychopharmacology, Clinical Psychopharmacology Award.

)

Uni of Cambridge
Hertfordshire
UK

J. Rajadas (Biography
J. Rajadas

Dr. Jayakumar Rajadas is currently working on the molecular mechanism of protein-initiated neurodegenerative disorders involved in Alzheimer’s and Lyme disease development using biophysical approaches. He is the founding director of the Biomaterials and Advanced Drug Delivery Laboratory at Stanford School of Medicine. Dr. Rajadas obtained a doctorate in Chemistry from Indian Institute of technology. He has 72 US patents and pending applications. He has also authored 188 papers.

)

Stanford University
Stanford, CA
USA

K. Suk (Biography
K. Suk

Dr. Kyoungho Suk is a member of editorial board for the journal. He is currently a professor of Department of Pharmacology, Kyungpook National University (KNU) School of Medicine (Daegu, Korea), and the director of Brain Science & Engineering Institute of KNU. He obtained his Ph.D. in Immunology at University of California at Davis in 1994, and M.S. degree in Immunology at Cornell University in 1991. He graduated from KNU with the genetic engineering major in 1989. Dr. Suk received his postdoctoral training in the division of Rheumatology, Yale University School of Medicine, and he has been a visiting professor at Harvard Medical School between 2008 and 2009, during which he participated in large-scale experiments and systems biology approaches toward understanding of disease networks and pathways. Dr. Suk is the author of more than 200 papers published in peer-reviewed journals and holds patents on various therapeutic targets and lead compounds that could be used for the diagnosis or therapy of neuroinflammatory and neurodegenerative diseases.

)

Kyungpook National University
Daegu
Republic of Korea

J. H. Abraini
Univ. of Caen - Basse Normandie
Caen
France

A. P. Aldenkamp (Biography
A. P. Aldenkamp

Professor Aldenkamp currently holds the Chair of Epileptology of Maastricht University Medical Centre (department of Neurology) and is Head of the Epilepsy Research Group of the Research School Mental Health and Neurosciences (MHeNS) of the University of Maastricht. In addition is the Head of the Department of Behavioural Research and Psychological Services of the Epilepsy Centre Kempenhaeghe (70 full-time staff members) and vice-chairman of the Research Institute of the institute and member of the central management team. He is currently the supervisor of 28 PhD students. In addition: Visiting Professor of Epileptology, Gent and Professor of Imaging, at the University of Technology in Eindhoven. Professor Aldenkamp is the Past Editor-in-Chief of the European Journal of Epileptology: SEIZURE since 2004, current co-editor-in-chief of Global Journal of Neuro Engineering and member of the Editorial Boards of 6 medical journals: Epilepsy and Behaviour, Acta NeurologicaScandinavica, Current Neuropharmacology, Clinical Neurology and neurosurgery, Current Pediatric Reviews and the Open Pediatric Medicine Journal. Professor Aldenkamp has published more than 310 publications (including chapters) and gave 444 international presentations.

)

Maastricht Univ. Med. Centre
Maastricht
The Netherlands

W. Araki (Biography
W. Araki

Dr. Araki received his medical doctor’s degree and Ph.D. degree at Kyoto University in 1985 and 1992, respectively. He had postdoctoral training at the National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan and Massachusetts Institute of Technology, U.S.A. He has been working as a section chief at the National Institute of Neuroscience, NCNP since 1998. He is an author of more than 60 peer-reviewed publications.

)

National Institute of Neuroscience
Tokyo
Japan

P.J. Atkinson (Biography
P.J. Atkinson

Dr. Atkinson obtained a doctorate (Ph.D) in Cell Physiology and Pharmacology from the University of Leicester (UK). In his role as Associate Director, Open Innovation, Peter contributes to the strategic direction and management of external scientific collaborations to enable target validation and lead generation within Eisai’s Neurology Business Group. This builds upon over 15 years working as a pharmacologist in neuroscience drug discovery for Wyeth (USA) and GlaxoSmithKline (UK). During this time Peter led preclinical neuroscience programs working extensively with global, multidisciplinary project teams. Peter has published a number of peer-reviewed scientific manuscripts within neuropharmacology and drug discovery research field.

)

Neuroscience and General Medicine PCU, Mosquito Way Hatfield Hertfordshire Eisai Ltd.
UK

B. A. Bahr (Biography
B. A. Bahr

Professor Bahr is trained in the fields of chemistry, molecular biology, and neuroscience and is the lead investigator for several grants studying Alzheimer’s disease and other brain disorders. Upon receiving his Ph.D. from University of California–Santa Barbara, Dr. Bahr joined the Center for the Neurobiology of Learning and Memory at University of California–Irvine as a researcher and lecturer. Currently, Dr. Bahr is the William C. Friday Chair and Distinguished Professor at the Pembroke campus of University of North Carolina. He has over 140 publications and several patents and pending patents on first-in-class neuroprotective compounds and their uses.

)

University of North Carolina - Pembroke Pembroke
North Carolina, NC
USA

L. Ballerini (Biography
L. Ballerini

Laura Ballerini graduated (MD) at the Università di Firenze, Italy in 1988. She was a Postdoctoral fellow (Physiology Department) at UCL (London, UK) from 1991 and later became assistant professor of Physiology at the Biophysics Sector of the International School for Advanced Studies (SISSA-ISAS) of Trieste, Italy in 1995. In 2002 Laura Ballerini became associate professor of Physiology at the Life Science Department, Università di Trieste, Italy, where in 2012 she became full professor of Physiology and from January 2016 to date she is chair professor of physiology at SISSA. She has provided important contribution to the understanding of spinal network physiology, plasticity and development. Recently, she has been working on the interactions between living neurons and micro-nano fabricated substrates or bioactive-composite containing carbon nanotubes. The scientific strategy at the core of these activities is the convergence between nanotechnology, chemistry and neurobiology.

)

University of Trieste
Trieste
Italy

A. M. Barr
University of British Columbia
Vancouver, BC
Canada

M. S. Beattie (Biography
M. S. Beattie

Michael S. Beattie, Ph.D. Dr. Beattie received his Ph.D. from The Ohio State University in 1977, where he stayed on to become the founding chair of the Department of Neuroscience, leaving for the University of California, San Francisco in 2006. He is currently Co-Director and Director of Research for the Brain and Spinal Injury Center (BASIC) at UCSF. His interests are in preclinical and clinical neurotrauma. He has published more than 150 peer reviewed papers and serves on multiple editorial and federal review panels.

)

University of California
San Francisco, CA
USA

F. Benedetti (Biography
F. Benedetti

Fabrizio Benedetti, M.D. is Professor of Neurophysiology and Human Physiology at the University of Turin Medical School, Turin, Italy, and Director of the Center for Hypoxia at the Plateau Rosa Labs in Breuil-Cervinia, Italy and Zermatt, Switzerland. He has been nominated member of The Academy of Europe and of the European Dana Alliance for the Brain. He identified some basic mechanisms of placebo responses across a variety of medical conditions. Recent books: Placebo Effects (Oxford, 2nd Edition, 2014), The Patient’s Brain (Oxford 2010), Placebo (Springer 2014). Recent awards: Highly Commended Book Award of the British Medical Association in 2009, Seymour Solomon Award of the American Headache Society in 2012, William S. Kroger Award of the American Society of Clinical Hypnosis in 2015, and EFIC-IBSA Award in 2015.

)

University of Turin Medical School
Turin
Italy

C. Bergmann
RWTH Aachen University
Aachen
Germany

P. G. Bhide (Biography
P. G. Bhide

Dr. Bhide is Eminent Scholar, Professor and Director of the Center for Brain Repair at Florida State University College of Medicine. He received his degree in Veterinary Medicine from Veterinary College, Bangalore, India, and a PhD in Neuroscience from the University of Aberdeen, Scotland. He obtained postdoctoral research training at University College London, England, Yale University, New Haven, CT, Massachusetts General Hospital, Boston, MA and Harvard Medical School, Boston, MA. Dr. Bhide was Associate Professor of Neurology at Harvard Medical School and Vice Chair for Neurology Research at Massachusetts General Hospital, in Boston until 2011, when he accepted his current position at FSU. Dr. Bhide is senior editor of the journal Developmental Neuroscience. He has served on various committees for a number of scientific organizations including the US National Institutes of Health, Veterans Administration, Autism Speaks and National Parkinson’s Foundation. Dr. Bhide founded Avekshan LLC, a Tallahassee based pharmaceutical company in 2013.

)

Massachusetts General Hospital
Charlestown, MA
USA

D. Boison (Biography
D. Boison

Having a passion for translational research I seek to translate fundamental mechanisms of biochemistry and energy homeostasis into novel therapeutic approaches for the treatment of neurological and psychiatric conditions. A major research effort is the development of adenosine augmentation therapies for the treatment of epilepsy. I graduated at the University of Cologne, Germany, in 1994 with a PhD in Biochemistry. In 1995 I started my independent research career at the University and Federal Institute of Technology in Zurich where I received the venia legendi in Cellular Pharmacology in 2005 for my work on cell-based adenosine augmentation therapies for epilepsy. That same year I joined Legacy Health in Portland, Oregon, where I am currently Chair and Director of the Robert Stone Dow Neurobiology Laboratories and Director of Basic and Translational Research of the Legacy Research Institute. In addition, I hold faculty appointments at Oregon Health and Science University and at Washington State University.

)

Dow Neurobiology Laboratories
Portland

A. Bordey (Biography
A. Bordey

Dr. Bordey obtained a doctorate (Ph.D.) in Neuroscience from the University Louis Pasteur, Strasbourg, France. Dr. Bordey also holds a Master in Organic Chemistry from the National School of Chemical Engineering (ESCIL) in Lyon, France and a master in Neuroscience from University Louis Pasteur, Strasbourg. Currently Dr. Bordey is a Professor at Yale School of Medicine. She has published more than 95 scientific publications and is a leading scientist in the field of brain development and epilepsy due to cortical malformations in monogenic disorders.

)

University School of Medicine
New Haven, CT
USA

R. Brandt (Biography
R. Brandt

Roland Brandt studied biochemistry and philosophy at the Universities of Tübingen and Berlin. After obtaining his doctoral degree at the Free University of Berlin, he continued as postdoctoral researcher at the Center for Neurologic Diseases (CND) at Harvard Medical School, Boston (USA). After returning to Germany, he became an independent research group leader at the Interdisciplinary Center for Neuroscience (IZN) of the University of Heidelberg. Since 2002 he is Full Professor and Head of the Department of Neurobiology at the University of Osnabrück. He has published more than 80 scientific publications, co-edited two books and is currently editorial board member of “Current Neuropharmacology”, review editor of “Frontiers in Neurodegeneration”, associate editor of “Biological Chemistry”, and honorary editorial board member of “Brain Research Bulletin”.

)

Universitaet Osnabrck
Osnabrück
Germany

R. M. Buijs (Biography
R. M. Buijs

Dr. Ruud M. Buijs obtained a doctorate (Ph.D.) in Neuroscience from the University of Amsterdam, The Netherlands. Dr. Buijs was senior scientist and associate director of the Netherlands Institute for Brain Research and currently is senior scientist at the Biomedical Research Institute at the UNAM Mexico. He has published more than 220 scientific publications mainly on hypothalamic integration mechanisms with an emphasis in the last 10 years on the influence of the biological clock the suprachiasmatic nucleus.

)

Universidad Nacional Autonoma de Mexico
Mexico

J. L. Cadet
Univ. College of Physicians and Surgeons
Baltimore, MD
USA

D. J. Calkins (Biography
D. J. Calkins

Dr. Calkins holds a doctorate (Ph.D.) in Neuroscience from the University of Pennsylvania, Philadelpha. He is currently Professor of Ophthalmology & Visual Sciences and Pharmacology in the Vanderbilt University School of Medicine and Director of the Vanderbilt Vision Research Center. He also is Vice Chair and Director for Research of the Vanderbilt Eye Institute. He has published more over 70 primary research articles, reviews and chapters and serves on the editorial board for several journals.

)

Vanderbilt University Medical Center
Nashville, TN
USA

C. A. Costa (Biography
C. A. Costa

Dr. Cristine Alves da Costa obtained a doctorate (PhD) in Toxicology from the Faculty of Pharmaceutical Sciences, University of São Paulo, USP, Brazil in 1997. Actually, Dr .Alves da Costa is a research director at INSERM and drives a team at the “Institute of Pharmacology Moléculaire et Cellulaire” (IPMC-CNRS). Her research interests include neurodegenerative diseases and brain tumors. Dr. Alves da Costa is currently an Editorial board member of this journal (Current Neuropharmacology), published by Bentham Science Publishers2E

)

Institut de Pharmacologie Molculaire et Cellulaire
France

A.K. Houghton
Merck & Co
West Point, PA
USA

F. A. Meunier (Biography
F. A. Meunier

Professor Frederic Meunier obtained his Masters degree in Neurophysiology at the Paris XI University, France in 1992 and completed his Ph.D in Neurobiology at the CNRS in Gif-sur-Yvette, France in 1996. He was the recipient of a European Biotechnology Fellowship and went on to postgraduate work at the Department of Biochemistry at Imperial College (1997-1999) and at Cancer Research UK (2000-2002) in London, UK. After a short sabbatical at the LMB-MRC in Cambridge (UK), he became a group leader at the School of Biomedical Sciences at the University of Queensland (Australia) in 2003. He joined the Queensland Brain Institute of the University of Queensland in 2007 and obtained an NHMRC senior research fellowship in 2009 renewed in 2014 with promotion. In 2014 he was also promoted to Professor and joined the Centre for Ageing Dementia Research at QBI. His laboratory works on the mechanism of vesicular trafficking in neurons and has identified critical roles for various proteins such as Munc18 and phosphoinositides such as phosphatidylinositol (4,5) bisphosphate in priming secretory vesicles. Prof Meunier has pioneered the use of single molecule imaging and super-resolution microscopy in Queensland.

)

The University of Queensland
Queensland
Australia

F. Nicoletti
Univ. Rome"da Sapienza"
Rome
Italy

M.A. Rogawski
Nat. Inst. Neuro. Disorders & Stroke
Bethesda, MD
USA

N. Akaike
Kumamoto Health Science University
Kumamoto
Japan

K. A. Alkadhi (Biography
K. A. Alkadhi

Dr. Karim Alkadhi earned a PhD in Pharmacology and Neuroscience from the university of New York, at Buffalo (SUNY) Medical School. Dr. Alkadhi’s lab focuses on studying the coincidence of chronic psychosocial stress and disorders that affect brain function such as chronic stress, Alzheimer’s disease, hypothyroidism and sleep deprivation. We recently have developed a preclinical rat model of Alzheimer’s disease to test the role of chronic stress in revealing prototype of the disease. Dr. Alkadhi has published more than 130 research articles, reviews and book chapters. He is an Editorial Board member of this journal (Current Neuropharmacology), published by Bentham Science Publishers.

)

University of Houston
Houston, TX
USA

G. W. Arbuthnott
Okinawa Institute of Science and Technology Promotion Corporation
Okinawa
Japan

C. S. Atwood (Biography
C. S. Atwood

Dr. Atwood obtained his Ph.D. in Biochemistry from the University of Western Australia, Perth, Australia. He has held faculty positions at Harvard Medical School and Case Western Reserve University prior to his current appointments as an Associate Professor in the University of Wisconsin-Madison Department of Medicine, and as a Health Science Specialist within the Geriatric Research, Education and Clinical Center at the William S. Middleton Memorial Veterans Administration Hospital, Madison. He has published more than 150 scientific publications, is an inventor on 8 issued U.S. patents and is a top cited author (h-index =45). He has received a number of awards for his teaching and research, including the Zenith Fellows Award from the Alzheimer’s Association.

)

University of Wisconsin-Madison School of Medicine and Public Health
Madison, WI
USA

R. Bakalova (Biography
R. Bakalova

Dr. Bakalova obtained a doctor (PhD) degree in Biochemistry & Biophysics from the Bulgarian Academy of Sciences, as well as a doctor of science (DSci) degree in Biological Sciences from the Sofia University “St. Kliment Ohridski”, Bulgaria. She has over 180 scientific publications and 12 Japanese patents. The main scientific interests of Dr. Bakalova are in the field of molecular imaging, molecular probe design, drug delivery systems, and nanomedicine. Recent studies are focused on redox-imaging and image-guided redox-modulation in cancer, as well as in nano-theranostics for cancer therapy.

)

National Institute of Radiological Sciences (NIRS)
Chiba
Japan

J. R. Bamburg (Biography
J. R. Bamburg

Dr. Bamburg obtained a bachelor’s degree in Chemistry from the University of Illinois, Urbana and a doctorate (Ph.D.) in Biochemistry from the University of Wisconsin, Madison. After a postdoctoral fellowship at Stanford Univ. he joined the faculty of Colorado State University where he holds the rank of professor emeritus. He has been a visiting professor in England, New Zealand, Australia and at Univ. California San Diego and the Scripps Research Institute, LaJolla. He has published more than 200 scientific papers and review articles in natural products chemistry, protein chemistry, cell and molecular biology, cell biology and neuroscience journals.

)

Colorado State University
Fort Collins, Co
USA

A. Baskys
University of California
Berkley, CA
USA

Al J Beitz
University of Minnesota
St. Paul, MN
USA

F. M. Benes
Harvard Medical School
Boston, MA
USA

B. Bettler (Biography
B. Bettler

Dr. Bettler received a Ph.D. from the University of Zurich. He then worked at Ciba in Basel, at the Salk Institute in San Diego, California and again at Ciba/Novartis in Basel. Since 2001 he has been full professor and Head of the Institute of Physiology, Medical Faculty of the University of Basel. Dr. Bettler has expertise in mental health disorders, neurotransmitter receptors and drug discovery, including the identification and development of allosteric modulators of GPCRs for central nervous system diseases. He has published more than 200 scientific publications and is a named inventor on several patents.

)

Physiologisches Institut
Basel
Switzerland

A. Blokland (Biography
A. Blokland

Dr. Arjan Blokland received his PhD in Neuroscience from Maastricht University in 1992. He did a post doc at the University of Cambridge in 1992. In 1993 he took a position as laboratory head at Tropon (CNS research Bayer. He returned to Maastricht University in 1996 as a Research Fellow. Currently, he is an associate Professor and Head of Department of Neuropsychology & Psychopharmacology at the Faculty of Psychology and Neuroscience. He published over 170 papers in international peer reviewed journals, and is a co-inventor of 4 patents (pending). He received various types of funding for his research and has many collaborations in Maastricht and the rest of the world.

)

Maastricht University
Maastricht
The Netherlands

V. Bolshakov
Harvard Medical School
Belmont, MA
USA

O. Boutaud
Vanderbilt University
Nashville, TN
USA

D. J. Brooks
Imperial College London
London
UK

G. Burnstock (Biography
G. Burnstock

Professor Geoffrey Burnstock completed his PhD at King's College and University College London. He was head of the Department of Zoology, Melbourne University (1964-1975) before moving to London to head the Department of Anatomy and Developmental Biology, UCL until 1997. He is currently President of the Autonomic Neuroscience Centre, University College Medical School, UK. He is a Fellow of the Australian Academy of Sciences (1971), Royal Society (1986) and Academy of Medical Sciences (1998). He was awarded the Royal Society Gold Medal (2000) and has over 1530 publications and an h-index of 138.

)

University College Medical School
London
UK

P. Calabresi
University of Perugia
Perugia
Italy

M. Capogna (Biography
M. Capogna

Prof. Marco Capogna received his PhD Degree in Neuroscience from the University of Pisa/Zurich. He is a professor of Neuroscience in the Aarhus University and an associated member of the MRC Brain Network Dynamics Unit, Oxford and the DANDRITE Aarhus University. He previously was an MRC Tenured Programme Leader at the Anatomical Neuropharmacology Unit, Oxford. He published about 75 research papers (e.g., published in Neuron, Nature Neuroscience and Journal of Neuroscience) and gave several invited lectures (ca. 50, e.g., Janelia Farm, VA). His field of interest includes Neurobiology of memory, Brain circuit dysfunction in psychiatric disorders and Interneuron and GABAergic neurotransmission.

)

University of Aarhus
Aarhus
Denmark

C. C. Felder (Biography
C. C. Felder

Dr. Christian Felder received a BS in Chemistry from the College of William and Mary, and his PhD in Biochemistry from Georgetown University School of Medicine. He is currently a Research Fellow in the Neuroscience Division at Eli Lilly & Co. in Indianapolis where he leads a drug development research lab focused on neurological and neuropsychiatric diseases. He is also the program Director for the external Lilly Innovation Fellowship Awards program (LIFA) and internal Lilly Research Labs post doc program. Dr. Felder has published over 130 scientific articles, reviews and book chapters and has had numerous invitations to speak at universities and international scientific conferences.

)

Lilly Corporate Center
Indianapolis, IN
USA

M. Kalinichev (Biography
M. Kalinichev

Dr. Mikhail Kalinichev obtained a doctorate (Ph.D.) in Behavioral Neuroscience from the Center for Molecular & Behavioral Neuroscience, Rutgers University (USA). Currently Dr. Kalinichev is a Director, In Vivo Neurology-Toxins in Ipsen Innovation, France. Previously, Dr. Kalinichev worked at Lundbeck pharmaceuticals (Denmark), Addex Therapeutics (Switzerland) and GlaxoSmithKline (UK). He has published more than 40 scientific publications.

)

H. Lundbeck A/S
Copenhagen
Denmark

P.C. Moser
Institut de Recherche Pierre Fabre
Castres
France

M. Popoli (Biography
M. Popoli

MP is Professor of Pharmacology at University of Milano (Italy). He was trained in Biochemistry/Cell Biology at University of Naples and received postdoctoral training at Int. Inst. Genet. Biophysics (Naples), and Dept. of Psychiatry at Washington University, (St. Louis, MO).

His studies have contributed to characterization of cellular/molecular mechanisms involved in pathophysiology of neuropsychiatric disorders and psychotropic drug action. He received a NARSAD Independent Investigator Award, and funding from national and international agencies, including EU.

He is author of 120 publications, and currently field editor or editorial board member of neuropsychopharmacology/biological psychiatry journals.

)

University of Milano
Milano
Italy

M J. Sheardown
Independent Consultant
Cambridge
UK


Guest Editor(s):

Karim Alkadhi
Department of Pharmacological and Pharmaceutical Sciences 521E Science and Research 2 Bldg.
Houston, TX
USA












Advertisement
Neurexpert partnership with Bentham Science Publishers

Related Journals




Related eBooks



Webmaster Contact: info@benthamscience.org Copyright © 2017 Bentham Science